We are live on ! Find out more
RVPHW

Reviva Pharmaceuticals Warrants
RVPHW

Delisted

RVPHW was delisted on the 12th of December, 2025.

Back to rankings

14 hedge funds and large institutions have $3.8M invested in Reviva Pharmaceuticals Warrants in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 14 → 14 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

4% less capital invested

Capital invested by funds: $3.97M → $3.8M (-$168K)

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCM
Context Capital Management
California
+$21.6K
2
WAM
Wolverine Asset Management
Illinois
+$7.85K

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$102K
2
Walleye Trading
Walleye Trading
New York
-$59.3K
3
GCIA
Gabelli & Co Investment Advisers
New York
-$17.9K
4
GF
Gabelli Funds
New York
-$15.5K
5
PAMP
Polar Asset Management Partners
Ontario, Canada
-$13.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$1.75M – – –
BCM
2
BlueCrest Capital Management
Jersey
$824K – – –
GCL
3
Glazer Capital LLC
New York
$466K -$13.6K -24,850 -3%
PAMP
4
Polar Asset Management Partners
Ontario, Canada
$197K -$13.7K -25,000 -8%
AA
5
AQR Arbitrage
Connecticut
$169K – – –
HF
6
HRT Financial
New York
$89K – – –
GCIA
7
Gabelli & Co Investment Advisers
New York
$75K -$17.9K -32,700 -23%
RCM
8
Rivernorth Capital Management
Florida
$72K -$10.1K -18,448 -15%
GF
9
Gabelli Funds
New York
$61K -$15.5K -28,279 -24%
Walleye Trading
10
Walleye Trading
New York
$40K -$59.3K -108,117 -65%
WAM
11
Wolverine Asset Management
Illinois
$28K +$7.85K +14,308 +51%
CCM
12
Context Capital Management
California
$27K +$21.6K +39,300 New
UBS Group
13
UBS Group
Switzerland
$1K -$6.2K -11,305 -91%
Walleye Capital
14
Walleye Capital
New York
$44 – – –
6CM
15
683 Capital Management
New York
– -$102K -200,000 Closed

RVPHW Hedge Fund Activity: Q4 2020 in Review

14 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q4 2020, worth a combined $3.8M — down 4.2% from $3.97M a quarter earlier.

Fund positioning in RVPHW was balanced in Q4 2020: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 7 trimmed.

The largest buyer was Context Capital Management, opening a new position worth an estimated $21.6K. The largest seller was 683 Capital Management, exiting entirely with an estimated $102K sold.

  • 14 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $3.8M of Reviva Pharmaceuticals Warrants stock for Q4 2020, down 4.2% quarter-over-quarter.
  • 1 fund opened new Reviva Pharmaceuticals Warrants positions in Q4 2020 and 1 closed out, a net change of 0 holders.
  • The largest Reviva Pharmaceuticals Warrants buyer in Q4 2020 was Context Capital Management, an estimated $21.6K added.
  • The largest Reviva Pharmaceuticals Warrants seller in Q4 2020 was 683 Capital Management, an estimated $102K sold.

Based on aggregated 13F filings for Q4 2020.